MITOCHONDRIAL CALCIUM UPTAKE IN ALZHEIMER?S DISEASE - ABSTRACT: ALZHEIMER'S DISEASE (AD) IS CHARACTERIZED B…
Federal financial assistance recorded from USAspending. This is not a procurement contract.
Research this with AI
Research smarter with AI
Analyze opportunities and compare insights across leading AI models.
ASST_NON_R00AG065445_075 · WAKE FOREST UNIVERSITY HEALTH SCIENCES · Department of Health and Human Services
Compare Multiple AI Models with SmartSoloExplore CaptureIQ IntelligenceAssistance award details
- Assistance award identifier
- ASST_NON_R00AG065445_075
- FAIN
- R00AG065445
- Recipient
- WAKE FOREST UNIVERSITY HEALTH SCIENCES
- Awarding agency
- Department of Health and Human Services
- Funding agency
- Department of Health and Human Services
- Assistance listing (CFDA)
- 93.866
- Total obligated
- $922,097
- Period
- Aug 15, 2020 – Aug 31, 2025
- Fiscal year
- 2022
- Place of performance state
- NC
- Source file
- FY2022_All_Assistance_Full_20261006.zip
Description
MITOCHONDRIAL CALCIUM UPTAKE IN ALZHEIMER?S DISEASE - ABSTRACT: ALZHEIMER'S DISEASE (AD) IS CHARACTERIZED BY THE LOSS OF MEMORY ACCOMPANIED BY NEURONAL CELL DEATH AND METABOLIC DYSFUNCTION. NUMEROUS STUDIES HAVE REPORTED A DYSREGULATION IN NEURONAL INTRACELLULAR CALCIUM (1CA2+) SIGNALING AS AN EARLY EVENT IN AD PATHOGENESIS. IT IS THOUGHT THAT A PROLONGED ELEVATION IN NEURONAL 1CA2+ PROMOTES EXCESSIVE MITOCHONDRIAL CALCIUM (MCA2+) UPTAKE, YET TO DATE NO STUDY HAS EXAMINED THE CONTRIBUTION OF MCA2+ UPTAKE TO DISEASE PROGRESSION. SINCE MCA2+ FLUX IS AN IMPORTANT REGULATOR OF CELLULAR RESPIRATION AND CELL DEATH, BOTH OF WHICH ARE INVOLVED IN AD PATHOGENESIS, WE HYPOTHESIZE THAT MCA2+ OVERLOAD IS A KEY CONTRIBUTOR TO AD PATHOLOGY AND MAY CONTRIBUTE TO METABOLIC DEFICITS AND NEURONAL DEMISE. TO DEFINE THE ROLE OF MCA2+ EXCHANGE IN AD WE HAVE GENERATED 3XTG-AD MUTANT MICE WITH NEURONAL-SPECIFIC DELETION OF MITOCHONDRIAL CALCIUM UNIPORTER (MCU), WHICH IS REQUIRED FOR MCA2+ UPTAKE. IN ADDITION, WE HAVE GENERATED A GAIN-OF-FUNCTION MUTANT MOUSE EXPRESSING THE RECENTLY IDENTIFIED MITOCHONDRIAL CALCIUM UNIPORTER BETA SUBUNIT (MCUB). MCUB WAS RECENTLY REPORTED AS A NEGATIVE REGULATOR OF MCA2+ UPTAKE AND WE HAVE OBSERVED SUBSTANTIAL CHANGES IN ITS EXPRESSION IN AD. THESE MODELS WILL ALLOW CAUSATIVE EXPERIMENTATION TO TEST IF MCA2+ UPTAKE DRIVES AD PROGRESSION. MICE WILL BE EXAMINED FOR ALTERATIONS IN MEMORY, AMYLOIDOSIS, TAU-PATHOLOGY, OXIDATIVE STRESS, SYNAPTIC AND METABOLIC FUNCTION. PRELIMINARY DATA SUGGEST THAT MCA2+ UPTAKE OVERLOAD IMPAIRS THE CLEARANCE OF MISFOLDED PROTEINS AND DYSFUNCTIONAL MITOCHONDRIA. THEREFORE, WE WILL MECHANISTICALLY EXAMINE THE LINK BETWEEN MCA2+ EXCHANGE AND AUTOPHAGIC AND MITOPHAGIC PATHWAYS. OPTIMALLY, THE PROPOSED STUDIES WILL DISCOVER NEW THERAPEUTIC TARGETS FOR AD AND ASSOCIATED MITOCHONDRIAL DYSFUNCTION AND PROVIDE A TRAINING AND RESEARCH PLATFORM TO PROMOTE THE PIS INDEPENDENT RESEARCH CAREER.